Hikma mulls GSK deal in Egypt and Tunisia

27 January 2021 - Deborah Wilkes

Premium

Hikma Pharmaceuticals has confirmed it is in discussions with GlaxoSmithKline (GSK) about the potential acquisition of certain pharmaceutical and consumer assets in Egypt and Tunisia.

Click tags below for more information on topics:

Hikma GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: